Patents by Inventor Deborah Ann Dilts

Deborah Ann Dilts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic fusion polypeptides
    Patent number: 9802987
    Abstract: In one aspect, the invention relates to an isolated polypeptide including the amino acid sequence of a carrier polypeptide and the amino acid sequence of an ORF2086 polypeptide. In another aspect, the invention relates to an immunogenic conjugate including ORF2086 polypeptide and a carrier polypeptide. The invention further includes immunogenic compositions and methods for inducing an immune response against Neisseria meningitidis in a mammal.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: October 31, 2017
    Assignee: Pfizer Inc.
    Inventors: Deborah Ann Dilts, Annaliesa Sybil Anderson, Kathrin Ute Jansen, Justin Keith Moran, Mark E Ruppen, Eugene Joseph Vidunas
  • IMMUNOGENIC FUSION POLYPEPTIDES
    Publication number: 20160017006
    Abstract: In one aspect, the invention relates to an isolated polypeptide including the amino acid sequence of a carrier polypeptide and the amino acid sequence of an ORF2086 polypeptide. In another aspect, the invention relates to an immunogenic conjugate including ORF2086 polypeptide and a carrier polypeptide. The invention further includes immunogenic compositions and methods for inducing an immune response against Neisseria meningitidis in a mammal.
    Type: Application
    Filed: March 5, 2014
    Publication date: January 21, 2016
    Inventors: Deborah Ann Dilts, Annaliesa Sybil Anderson, Kathrin Ute Jansen, Justin Keith Moran, Mark E Ruppen, Eugene Joseph Vidunas
  • Polysaccharides of
    Patent number: 7527949
    Abstract: The invention is directed to immunogenic compositions comprising polysaccharides and polysaccharide-protein conjugates that are useful to induce or detect the production of antibodies specific for H. pylori. The invention is also directed to methods of purifying the H. pylori polysaccharides from bacteria. The polysaccharide may be incorporated into an immunogenic composition or used in vitro to assay for the presence of H. pylori antibodies in a sample or biological fluid.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: May 5, 2009
    Assignee: Wyeth Holdings Corporation
    Inventors: Mario Artur Monteiro, James Fulginiti, Deborah Ann Dilts